02.07.2024 • NewsMaire TecnimontNextChemfertilizer

NextChem to Conduct Feasibility Study on Low-Carbon Fertilizer

Italian engineering group Maire Tecnimont announced that its subsidiary NextChem, which specializes in sustainable technology solutions, has been awarded a feasibility study and a pre-FEED (front-end engineering design) contract by FertigHy to use NX Stami Green Ammonia and NX Stami Nitric Acid technologies.

The FertigHy consortium, established in 2023, is composed of a cross-value chain combination of shareholders, including EIT InnoEnergy, RIC Energy, Maire, Siemens Financial Services, InVivo and Heineken. This consortium aims to drive the continuous decarbonization of the European economy.

The first plant to be built in France, which is scheduled to start construction in 2027, will produce 500,000 t/y of low-carbon nitrogen-based fertilizers, from hydrogen obtained by renewable and low carbon electricity. FertigHy aims to replicate this integrated concept in other European countries to potentially reduce single plant emissions by up to one million tons of CO2 per year.

Alessandro Bernini, Maire’s CEO, commented: “The fertilizers industry is a strategic sector for countries’ economies, and we are proud to contribute to its sustainability in Europe and globally. Maire, leveraging on the integrated approach ranging from the project development to the execution capabilities, can provide the fertilizer business with technology solutions that help the industry achieve the decarbonization targets required by EU regulations.”

© Africa Studio – stock.adobe.com
© Africa Studio – stock.adobe.com

Company

Maire Tecnimont SpA

Via Gaetano De Castillia 6A
20124 Milan
Italy

Company contact







Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.